Grinta
Grinta is a Cairo-based B2B digital pharmaceutical marketplace founded in 2021 that connects pharmaceutical suppliers with over 14,000 independent pharmacies across Egypt, offering e-commerce sourcing, inventory financing, and automation services, with recent expansion into primary healthcare.
- Company typePrivate
- Founded2021
- HeadquartersCairo, Egypt
- Headcount1–10
- GTM typeB2B
- OfferingDigital Commerce or Content
What Grinta does
Grinta is a Cairo-based B2B digital pharmaceutical marketplace founded in 2021 that operates a supply chain platform connecting pharmaceutical suppliers with independent pharmacies across Egypt. The company's core product is a B2B e-commerce platform enabling independent pharmacists to source pharmaceutical products, manage inventory, and access working capital through embedded inventory financing. The platform also provides pharmacy automation services for inventory management and ordering. Grinta serves over 14,000 independent pharmacies across Egypt and has facilitated more than 100,000 orders through the platform.
The company's revenue model is based on marketplace commissions on transactions between pharmaceutical suppliers and independent pharmacies facilitated through its digital platform. Its go-to-market is sales-led, targeting SMB independent pharmacies that lack access to competitive supplier networks and working capital. Grinta has pursued an acquisition-led consolidation strategy, completing three acquisitions: EME International (2022), Auto-Cure (2023), and Citi Clinic (2025). The Auto-Cure acquisition expanded reach to over 400 pharmacies in Alexandria, while Citi Clinic — a primary healthcare service chain — gave Grinta access to over 150,000 patients and marked its entry into the primary care sector.
Grinta has raised approximately $9.5 million in total funding, including an $8 million seed round in November 2022 led by Raed Ventures and Nclude, with participation from Endeavor Catalyst and 500 Global. The company secured additional strategic investment from Beltone Venture Capital alongside the Citi Clinic acquisition to support expansion into primary healthcare services across Egypt and East Africa. While Grinta's positioning references AI/ML capabilities, specific AI technology, models, or proprietary tooling are not documented in available sources.
Grinta firmographics
Firmographics- Name
- Grinta
- Legal name
- Grinta
- Website
- https://grinta.ai/home
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Grinta is a Cairo-based B2B digital pharmaceutical marketplace founded in 2021 that connects pharmaceutical suppliers with over 14,000 independent pharmacies across Egypt, offering e-commerce sourcing, inventory financing, and automation services, with recent expansion into primary healthcare.
- Ownership category
- akta.pro rank
Grinta industry classification
Industry- Product category
- B2B Pharmaceutical Marketplace
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)
- akta.pro secondary industries
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)
Keywords
Where Grinta is headquartered
LocationHeadquarters
- HQ city
- Cairo
- HQ country
- Egypt
- HQ region
- Africa
Offices1 record
Markets served
Grinta business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- B2B Marketplace Transactions: Platform facilitates transactions between pharmaceutical suppliers and independent pharmacies, likely earning transaction fees or commissions on orders placed through the platform
Go-to-market motion1 record
Distribution channels1 record
Grinta product offering
Product offeringCore offering
Grinta operates a B2B digital pharmaceutical marketplace that digitizes the pharmaceutical supply chain for independent pharmacies in Egypt. The platform enables pharmacists to source products directly from suppliers, manage inventory, and access working capital through fintech-enabled inventory financing. It also provides automation services for ordering and inventory management, and has expanded into adjacent primary healthcare via the Citi Clinic acquisition.
Product overview
Grinta operates as a unified B2B digital pharmaceutical marketplace and fintech platform. The core Grinta Platform serves independent pharmacies across Egypt, providing e-commerce, inventory financing, and supply chain automation. The product portfolio includes two acquired brands: Auto-Cure (a B2B online pharmacy platform serving pharmacists in Alexandria) and Citi Clinic (a primary healthcare service chain). These acquisitions expanded Grinta's reach to over 14,000 pharmacies and 150,000 patients, enabling end-to-end pharmaceutical supply chain digitization and healthcare service expansion.
Differentiator
Problem solved
Functional benefit
Products and services
- Grinta Platform B2B digital pharmaceutical marketplace and fintech-enabled platform that digitizes the pharmaceutical supply chain for independent pharmacies in Egypt, offering product sourcing, inventory financing, automation, and e-commerce services.
- Auto-Cure
Quantifiable outcome
- Over 14,000 pharmacies served across Egypt
- +2 more outcomes
Companies that use Grinta
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
Grinta technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Grinta partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Citi CliniccorePrimary healthcare service chain in Egypt acquired by Grinta, giving access to over 150,000 patients and marking Grinta's entrance into the care sector with expansion plans across Egypt and East Africa.
- Auto-CurecoreAlexandria-based online pharmacy platform acquired by Grinta to expand presence in Egypt. The acquisition added over 400 pharmacies in Alexandria and enhanced services in inventory financing and automation. This was Grinta's third acquisition.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Grinta competitors and assessment
Company assessmentDirect peers
- mPharma: Africa-focused B2B pharmaceutical supply-chain and inventory-financing platform serving independent pharmacies. Closest direct peer in business model, target customer, and fintech-pharma hybrid approach.
- DrugStoc: Nigeria-based B2B digital pharmaceutical marketplace connecting manufacturers and pharmacies with embedded financing. Direct comparable on B2B e-commerce model, supply-chain digitization, and SMB-pharmacy focus.
- Remedial Health: Nigeria-based B2B platform providing pharmaceutical procurement, inventory financing, and operations tools to retail pharmacies. Closely aligned with Grinta's marketplace + financing playbook.
- RxAll: Nigeria-based B2B pharma marketplace leveraging AI for quality verification and supply chain. Direct peer on AI/ML-enabled pharma distribution targeting African independents.
- Yodawy: Egypt-based digital pharmacy and pharma-benefits management platform connecting insurers, pharmacies, and patients. Direct in-country peer with overlapping pharmacy digitization and care-channel focus.
Emerging players
- Chekkit Technologies: African pharma supply-chain technology company focused on anti-counterfeiting and traceability. Adjacent tech-layer peer addressing trust and verification in the same B2B pharma distribution space.
- Pharmarun: Nigeria-based B2B and B2C pharmaceutical distribution platform. Emerging peer with overlapping B2B pharmacy procurement capabilities though heavier consumer-side emphasis.
Broad incumbents
- Medplus: Large Nigerian retail pharmacy chain with growing distribution and digital capabilities. Broad incumbent illustrating the integrated pharmacy-retail-plus-distribution model Grinta may evolve toward.
- Truepill: US-based digital pharmacy and B2B pharmacy infrastructure platform offering telehealth, fulfillment, and supply chain services. Comparable as a tech-enabled pharmacy supply chain and care platform, though in a developed market.
Regional players
- Alma Health: MENA-focused digital health and pharmacy platform. Regionally adjacent player operating in the same broader market geography with overlapping digital-pharmacy ambitions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Grinta social profiles
Digital presenceGrinta financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grinta leadership team
Management profileNumber of profiles
Profiles2 records
Grinta subsidiaries and ownership
Company hierarchySubsidiaries2 records
Grinta funding detail
Funding detailFunding overview
Funding rounds3 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grinta M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grinta
What does Grinta do?
Grinta operates a B2B digital pharmaceutical marketplace that digitizes the pharmaceutical supply chain for independent pharmacies in Egypt. The platform enables pharmacists to source products directly from suppliers, manage inventory, and access working capital through fintech-enabled inventory financing. It also provides automation services for ordering and inventory management, and has expanded into adjacent primary healthcare via the Citi Clinic acquisition.
Is Grinta a public or private company?
Grinta is a private company. It is classified as venture growth investor backed and is currently operating.
When was Grinta founded?
Grinta was founded in 2021. It employs 1 to 10 people.
Where is Grinta based?
Grinta is headquartered in Cairo, Egypt, in the Africa region.
How does Grinta make money?
One revenue line is on record: B2B Marketplace Transactions.
Who are Grinta's main competitors?
Direct peers on record are mPharma, DrugStoc, Remedial Health, RxAll and Yodawy. Emerging players are Chekkit Technologies and Pharmarun. Broad incumbents are Medplus and Truepill. Alma Health is listed as a regional player.
Does Grinta have an API?
No public API is recorded for Grinta.
What industry is Grinta in?
Grinta's product category is B2B Pharmaceutical Marketplace. Its primary akta.pro industry code is CRAFAHAG, Medical, Dental & Lab Supply Marketplaces, with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 42421 and its SIC code is 5122.